The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification.

KCGS chemogenomic set drug discovery druggable genome kinase inhibitor phenotypic screening protein kinase small molecules understudied kinase

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
08 Jan 2021
Historique:
received: 08 12 2020
accepted: 29 12 2020
entrez: 12 1 2021
pubmed: 13 1 2021
medline: 31 3 2021
Statut: epublish

Résumé

We describe the assembly and annotation of a chemogenomic set of protein kinase inhibitors as an open science resource for studying kinase biology. The set only includes inhibitors that show potent kinase inhibition and a narrow spectrum of activity when screened across a large panel of kinase biochemical assays. Currently, the set contains 187 inhibitors that cover 215 human kinases. The kinase chemogenomic set (KCGS), current Version 1.0, is the most highly annotated set of selective kinase inhibitors available to researchers for use in cell-based screens.

Identifiants

pubmed: 33429995
pii: ijms22020566
doi: 10.3390/ijms22020566
pmc: PMC7826789
pii:
doi:

Substances chimiques

Protein Kinase Inhibitors 0
Small Molecule Libraries 0
Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : 1R44TR001916-02
Pays : United States
Organisme : Innovative Medicines Initiative
ID : 875510
Organisme : NIH HHS
ID : 1U24DK116204-01
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA218442
Pays : United States
Organisme : NIH HHS
ID : 1R01CA218442-01
Pays : United States

Références

Drug Discov Today. 2019 Nov;24(11):2111-2115
pubmed: 31278990
Nat Methods. 2016 Jun;13(6):521-7
pubmed: 27135972
Int J Mol Sci. 2017 Aug 31;18(9):
pubmed: 28858266
Nat Rev Mol Cell Biol. 2018 Jun;19(6):349-364
pubmed: 29618831
EMBO J. 2017 Feb 15;36(4):549-564
pubmed: 28028054
Pharmacol Res. 2019 Jun;144:19-50
pubmed: 30877063
Cell Chem Biol. 2018 Feb 15;25(2):206-214.e11
pubmed: 29174542
Cell Chem Biol. 2019 Jul 18;26(7):970-979.e4
pubmed: 31056464
Nat Rev Drug Discov. 2018 May;17(5):377
pubmed: 29567993
Acta Pharmacol Sin. 2017 Apr;38(4):513-523
pubmed: 28042876
SLAS Discov. 2020 Aug;25(7):801-811
pubmed: 32458721
Mol Cell. 2016 Nov 17;64(4):835-849
pubmed: 27818143
Nat Chem Biol. 2013 Jan;9(1):3-6
pubmed: 23238671
J Med Chem. 2010 Feb 11;53(3):1098-108
pubmed: 20070106
Mol Biol Rep. 2018 Oct;45(5):815-828
pubmed: 29978381
Nat Biotechnol. 2005 Mar;23(3):329-36
pubmed: 15711537
Science. 2002 Dec 6;298(5600):1912-34
pubmed: 12471243
Nat Rev Drug Discov. 2018 May;17(5):353-377
pubmed: 29545548
Adv Exp Med Biol. 2019;1206:67-83
pubmed: 31776980
Heart Fail Rev. 2017 Nov;22(6):843-859
pubmed: 28702857
PLoS One. 2017 Aug 2;12(8):e0181585
pubmed: 28767711
Expert Rev Anticancer Ther. 2018 Dec;18(12):1249-1270
pubmed: 30259761
Nature. 2011 Feb 10;470(7333):163-5
pubmed: 21307913
Am J Transl Res. 2017 Mar 15;9(3):845-873
pubmed: 28386317
Brain. 2020 Jun 1;143(6):1651-1673
pubmed: 32206784
Mol Cancer. 2018 Feb 19;17(1):48
pubmed: 29455673
Sci Rep. 2017 Mar 03;7:42717
pubmed: 28256516
SLAS Discov. 2019 Jun;24(5):505-514
pubmed: 31034310
Data Brief. 2019 Jul 18;25:104284
pubmed: 31453287
Nat Chem Biol. 2015 Aug;11(8):536-41
pubmed: 26196764
Curr Protoc Chem Biol. 2017 Jun 19;9(2):96-116
pubmed: 28628201
J Med Chem. 2010 Feb 25;53(4):1413-37
pubmed: 20166671
J Med Chem. 2011 Jan 13;54(1):54-66
pubmed: 21128601
J Neurol Sci. 2019 Jul 15;402:121-130
pubmed: 31129265
J Chem Inf Model. 2016 Sep 26;56(9):1654-75
pubmed: 27482722
Oncotarget. 2016 Jul 12;7(28):43997-44012
pubmed: 27259267
Nat Chem Biol. 2010 Mar;6(3):166-169
pubmed: 20154661
EMBO J. 2019 Oct 15;38(20):e101443
pubmed: 31424118
Cell Chem Biol. 2019 May 16;26(5):765-777.e3
pubmed: 30956147
Science. 2017 Dec 1;358(6367):
pubmed: 29191878
Nat Rev Drug Discov. 2017 Apr;16(4):285-296
pubmed: 28104905
Nat Biotechnol. 2016 Jan;34(1):95-103
pubmed: 26501955
J Med Chem. 2008 Dec 25;51(24):7898-914
pubmed: 19035792
Sci Transl Med. 2017 May 31;9(392):
pubmed: 28566431

Auteurs

Carrow I Wells (CI)

Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Hassan Al-Ali (H)

The Miami Project to Cure Paralysis, Peggy and Harold Katz Family Drug Discovery Center, Sylvester Comprehensive Cancer Center, and Departments of Neurological Surgery and Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Truvitech LLC, Miami, FL 33136, USA.

David M Andrews (DM)

AstraZeneca, Darwin Building, Cambridge Science Park, Cambridge CB4 0WG, UK.

Christopher R M Asquith (CRM)

Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Alison D Axtman (AD)

Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Ivan Dikic (I)

Institute of Biochemistry 2, Faculty of Medicine, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60438 Frankfurt am Main, Germany.
Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Max-von-Laue-Str. 15, 60438 Frankfurt am Main, Germany.
Max Planck Institute of Biophysics, Max-von-Laue-Str. 3, 60438 Frankfurt am Main, Germany.

Daniel Ebner (D)

Nuffield Department of Medicine, Target Discovery Institute, University of Oxford, Oxford OX3 7FZ, UK.

Peter Ettmayer (P)

Boehringer Ingelheim RCV GmbH & Co KG, 1121 Vienna, Austria.

Christian Fischer (C)

MSD, 33 Avenue Louis Pasteur, Boston, MA 02115, USA.

Mathias Frederiksen (M)

Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel, Switzerland.

Robert E Futrell (RE)

Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Nathanael S Gray (NS)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Stephanie B Hatch (SB)

MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Roosevelt Drive, Oxford OX3 7XB, UK.

Stefan Knapp (S)

Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Max-von-Laue-Str. 15, 60438 Frankfurt am Main, Germany.
Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany.
Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany.

Ulrich Lücking (U)

Bayer Pharma AG, Drug Discovery, Müllerstrasse 178, 13353 Berlin, Germany.

Michael Michaelides (M)

Oncology Discovery, AbbVie, 1 North Waukegan Road, North Chicago, IL 60064, USA.

Caitlin E Mills (CE)

Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.

Susanne Müller (S)

Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Max-von-Laue-Str. 15, 60438 Frankfurt am Main, Germany.
Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany.
Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany.

Dafydd Owen (D)

Discovery Network Group, Pfizer Medicine Design, Cambridge, MA 02139, USA.

Alfredo Picado (A)

Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Kumar S Saikatendu (KS)

Global Research Externalization, Takeda California, Inc., 9625 Towne Center Drive, San Diego, CA 92121, USA.

Martin Schröder (M)

Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Max-von-Laue-Str. 15, 60438 Frankfurt am Main, Germany.
Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany.
Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany.

Alexandra Stolz (A)

Institute of Biochemistry 2, Faculty of Medicine, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60438 Frankfurt am Main, Germany.
Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Max-von-Laue-Str. 15, 60438 Frankfurt am Main, Germany.
Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany.

Mariana Tellechea (M)

Institute of Biochemistry 2, Faculty of Medicine, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60438 Frankfurt am Main, Germany.
Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Max-von-Laue-Str. 15, 60438 Frankfurt am Main, Germany.
Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany.

Brandon J Turunen (BJ)

GlaxoSmithKline, Chemical Biology, 1250 S Collegeville Rd, Collegeville, PA 19426, USA.

Santiago Vilar (S)

Truvitech LLC, Miami, FL 33136, USA.

Jinhua Wang (J)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

William J Zuercher (WJ)

Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Timothy M Willson (TM)

Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

David H Drewry (DH)

Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH